insights into the biology of high-risk myeloma and advances being made in this space
Published 1 year ago • 126 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
3:59
the importance of accurately defining high-risk myeloma and current risk stratification systems
-
2:49
defining high-risk myeloma
-
2:20
ultra high-risk myeloma
-
2:36
high-risk disease biology in multiple myeloma
-
4:28
advances in the classification of agressive myeloma
-
1:11
the future of myeloma therapy and where the treatment landscape is moving
-
5:59
what is hrmm (high-risk multiple myeloma)?
-
4:04
the future of myeloma treatment and the possibility of cure
-
6:23
results of maintenance therapy in high-risk myeloma patients | ajay nooka, md, mph, facp | asco 2023
-
3:10
is there a benefit to rituximab maintenance after first-line bendamustine-rituximab for mcl?
-
3:05
recent advances in newly diagnosed multiple myeloma and the importance of patient perspectives
-
1:30
the genomic definition of ultra-high-risk multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
1:46
insights into mass spectrometry-based proteomics in multiple myeloma research
-
6:20
advances in the treatment of high-risk multiple myeloma
-
0:59
defining the origins of multiple myeloma
-
1:25
the importance of identifying and understanding high-risk multiple myeloma
-
1:11
single-cell multiomics analysis and the role of phf19 expression in high-risk multiple myeloma
-
4:04
defining and managing high-risk myeloma
-
3:20
myeloma and the microenvironment
-
1:57
using molecular abnormalities for risk stratification in multiple myeloma at the time of diagnosis